Català
|
Español
|
English
Anmeldung
Gruppen
Forscher/innen
Ergebnisse
MA. ANTONIA
SALUD SALVIA
TEU
Hospital Universitario Puerta del Mar
Cádiz, España
Sie sind in
Zusammenarbeiten
Hospital Universitario Puerta del Mar
Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta del Mar (2)
2017
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82
2015
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: The phase II AVAXIRI study
BMC Cancer, Vol. 15, Núm. 1
Contacta
Avís legal